Verisante Technology Inc.

OTC: VRSEF · Healthcare · Medical - Devices

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 33DQ —GM —SS 41

v0.1 · 35/100 weight · pillars only

↑ return on assets, listing tenure · ↓ Altman-Z, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

$22.3k

Employees

Market cap

$164.5k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income$22.3k31.2k CAD2025

Operating income-$82.8k-115.8k CAD2025

Total assets$3.6k4.9k CAD2025

Liabilities$32.0k43.8k CAD2025

Equity-$28.4k-38.9k CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Verisante Technology Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.

Peers · Healthcare

Health Logic Interactive Inc.——GRI Bio, Inc.——Garrison Film Productions Inc.——BioLife Sciences Inc.——

Key facts

CEOThomas A. Braun

SectorHealthcare

IndustryMedical - Devices

HeadquartersVancouver, BC

ExchangeOTC: VRSEF

Employees18

IPO date2011-05-06

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.